Perez, E. A., Hurvitz, S. A., Amler, L. C., Mundt, K. E., Ng, V., Guardino, E., & Gianni, L. (2014). Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: A randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer. Breast Cancer Res.

Perez, Edith A., Sara A. Hurvitz, Lukas C. Amler, Kirsten E. Mundt, Vivian Ng, Ellie Guardino, và Luca Gianni. "Relationship between HER2 Expression and Efficacy With First-line Trastuzumab Emtansine Compared With Trastuzumab Plus Docetaxel in TDM4450g: A Randomized Phase II Study of Patients With Previously Untreated HER2-positive Metastatic Breast Cancer." Breast Cancer Res 2014.

Perez, Edith A., et al. "Relationship between HER2 Expression and Efficacy With First-line Trastuzumab Emtansine Compared With Trastuzumab Plus Docetaxel in TDM4450g: A Randomized Phase II Study of Patients With Previously Untreated HER2-positive Metastatic Breast Cancer." Breast Cancer Res 2014.